In this free webinar, see how biopharma organizations are translating real-world data into actionable opportunities to increase patient access to diagnosis and treatment in Alzheimer’s disease. The featured speakers will share how high-fidelity real-world laboratory data enables insights into patient journeys in routine clinical settings. The speakers will also share biopharma and patient perspectives on how diagnostic data can accelerate patient access to diagnosis and treatment.
TORONTO, June 18, 2026 /PRNewswire/ — Alzheimer’s disease is entering a new era of innovation, with advances in neurological biomarkers and diagnostic evaluation expanding options for earlier and more accessible assessment. As testing moves into primary care settings, patient journeys are evolving. Understanding how and when patients are diagnosed and treated is critical for enabling better decision-making across the healthcare ecosystem.
In this webinar, four featured speakers will share complementary perspectives on how real-world diagnostic data can generate insights to accelerate progress in Alzheimer’s disease. Subject matter experts will provide an overview of rapidly evolving diagnostics, followed by specific use cases to examine patient journeys. This walk-through will also highlight how biopharma organizations are translating real-world data into actionable opportunities to increase patient access to diagnosis and treatment. To conclude, a patient advocacy pioneer will share how patient experiences have informed a collaborative framework and issue a call to action to deliver answers and options to patients and families faster.
The session will benefit:
- Therapeutic area, clinical development, real-world data/evidence and commercial leaders at pharma and biotech organizations
- Research and patient advocacy organizations for Alzheimer’s disease
Attendees will gain insight into:
- The rapidly evolving diagnostics available for evaluation of Alzheimer’s disease
- How high-fidelity real-world laboratory data enables insights into patient journeys in routine clinical settings
- Biopharma and patient perspectives on how diagnostic data can accelerate patient access to diagnosis and treatment
Register for the live webinar on Thursday, July 9, 2026, at 1 p.m. EDT (10 a.m. PDT), featuring:
- Dan Jacob (Moderator), VP & general manager, Real World Data Solutions, Labcorp
- Joseph Volpe, Ph.D., executive director, Scientific Strategy & Commercialization, Labcorp
- David Alfego, Ph.D., director, Data Science & RWE, Labcorp
- Wendy Webber Nelson, Ph.D., president & founder, Boston Biotech Forum
- Eli Shobin, Ph.D., senior director, U.S. Diagnostic Strategy & Commercialization, Biogen
For more information, or to register for this event, visit Leveraging real-world diagnostic data to accelerate Alzheimer’s research and care.
ABOUT XTALKS
Xtalks — The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.
Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what’s next.
To learn more about Xtalks, visit www.xtalks.com.
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/.
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/leveraging-real-world-diagnostic-data-to-accelerate-alzheimers-research-and-care-upcoming-webinar-hosted-by-xtalks-302803888.html
SOURCE Xtalks
